← back to search

Juan Carlos Rodrı́guez

Repsol (Spain) · NL
Area of research
Molecular Medicine · Infectious Diseases
Research interest
Research interests include Antibiotic Resistance in Bacteria, Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, and Antibiotics Pharmacokinetics and Efficacy.
h-index
42
citations
7,286
works
605
NIH funding
primary concept
email

Recent publications

Clinical Impact of Implementing a Specific Clinical Pathway for the Management of Clostridioides difficile Infection.
2026cited by 1position: contributordoi
Adult RSV hospitalizations in Spain: clinical characteristics and risk factors for ICU admission, prolonged stay, and mortality across six seasons (2016-2017 to 2021-2022).
2026cited by 0position: contributordoi
Dynamics of the microbiota in patients with Clostridioides difficile: Recurrence, treatment, sex, and immunosuppression.
2026cited by 0position: contributordoi
Suboptimal Linkage to Care of Delta-Infected Patients in an Area with Increasing Migration-Driven Prevalence of Hepatitis D in Recent Years.
2026cited by 0position: contributordoi
Antimicrobial Susceptibility of <i>Clostridioides difficile</i> in Spain: Multicenter Retrospective Cohort Study.
2026cited by 0position: contributordoi
Multicenter evaluation of the QuickMIC<sup>®</sup> rapid AST system in clinical practice: impact on turnaround time compared to routine AST systems.
2026cited by 0position: contributordoi
Community-Based Screening for HIV and Viral Hepatitis Using Dried Blood Spots in a Migrant Population in Spain: The HEPINMIGRA Study.
2026cited by 0position: contributordoi
Increasing Burden of Clostridioides difficile–Related Hospitalizations in Spain: A 26-Year Nationwide Study (1997–2022)
2026cited by 0position: contributordoi
Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studies.
2025cited by 13position: contributordoi
Genomic surveillance reveals different transmission patterns between third-generation cephalosporin and carbapenem resistance in Klebsiella pneumoniae in the Comunidad Valenciana (Spain), 2018-2020.
2025cited by 3position: contributordoi
Effectiveness of immunization strategies for preventing severe acute respiratory infection during the 2023/2024 season in a Spanish health department.
2025cited by 2position: contributordoi
Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: A post hoc emulation trial of the SIMPLIFY trial.
2025cited by 2position: contributordoi
In-Hospital Death and Risk Factors in Adults With Influenza in Spain (2016-2022): A Cross-Sectional Study With Focus on Older Patients.
2025cited by 2position: contributordoi
Efficacy and safety of dexamethasone compared to placebo in patients with severe influenza infection. (FLUDEX study): a study protocol for a randomised controlled trial in Spain.
2025cited by 1position: contributordoi
Nanopore versus Illumina to study the gut bacterial diversity of sows and piglets between farms with high and low health status.
2025cited by 1position: contributordoi
A national population-based study of mortality and risk factors in COVID-19-hospitalized patients in Spain (2020-2021).
2025cited by 0position: contributordoi
In-Hospital Death and Risk Factors in Adults With Respiratory Syncytial Virus in Spain (2016-2023). A Cross-Sectional Study With Focus on Older Patients.
2025cited by 0position: contributordoi
Diagnostic accuracy of SARS-CoV-2 and influenza antigen test in Omicron age in hospital emergency department: real-life analysis during 2023.
2025cited by 0position: contributordoi
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.
2024cited by 27position: contributordoi
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial.
2024cited by 23position: contributordoi
Impact of influenza related hospitalization in Spain: characteristics and risk factor of mortality during five influenza seasons (2016 to 2021).
2024cited by 12position: contributordoi
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
2024cited by 6position: contributordoi
Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment.
2024cited by 6position: contributordoi
Genomic Analysis of Antimicrobial Resistance in <i>Pseudomonas aeruginosa</i> from a "One Health" Perspective.
2024cited by 4position: contributordoi
Evaluation of the quickmic system in the rapid diagnosis of Gram-negative bacilli bacteremia.
2024cited by 3position: contributordoi
Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score-adjusted retrospective cohort study.
2024cited by 3position: contributordoi
Comparison of Different Methods for Assaying the In Vitro Activity of Cefiderocol against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains: Influence of Bacterial Inoculum.
2024cited by 2position: contributordoi
Identification of Antimicrobial-Resistant Zoonotic Bacteria in Swine Production: Implications from the One Health Perspective.
2024cited by 1position: contributordoi
[Positioning proposal on the recommendations for the use of masks in health centers after the cessation of the mandatory use in Spain].
2024cited by 0position: contributor
[In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug].
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 31 papers (2019–2026)Esperanza Merino · Conselleria de Sanidad Universal y Salud Pública13 papers (2021–2026)José-Manuel Ramos-Rincón · Clarivate PLC11 papers (2021–2026)Maria Paz Ventero · Universidad Complutense de Madrid10 papers (2021–2026)Vicente Boix · BMJ Publishing Group8 papers (2020–2025)Oscar Moreno-Pérez · Universitat de Miguel Hernández d'Elx8 papers (2020–2024)Héctor Pinargote-Celorio · Hospital General Universitario Dr. Balmis7 papers (2022–2026)Pilar González-delaAleja · Hospital General Universitario de Alicante Doctor Balmis5 papers (2021–2026)Silvia Otero-Rodriguez · Instituto Bernabeu5 papers (2022–2026) · 5 papers (2020–2024)P. Chico-Sánchez · University of Alicante5 papers (2022–2024)José Sánchez-Payá · Hospital General Universitario de Alicante Doctor Balmis5 papers (2020–2026)Nicolas Merchante · Universitat de Miguel Hernández d'Elx4 papers (2023–2026)Adelina Gimeno Gascón · Elsevier, Inc.4 papers (2019–2023)Iñaki Comas · Centre for Biomedical Network Research on Rare Diseases3 papers (2019–2024)Jesús Rodríguez-Baño · Instituto de Investigación Biomédica de Málaga3 papers (2024–2025)Jara Llenas-Garcìa · Hospital General Universitario de Elche3 papers (2023–2026)Carmen Molina-Pardines · Universitat de Miguel Hernández d'Elx3 papers (2021–2023)Sergio Reus · Universitat de Miguel Hernández d'Elx3 papers (2022–2026)Mario López-Pérez · Miguel Hernandez University3 papers (2020–2024)